PDS Biotechnology Corporation (NASDAQ:PDSB)

PDS Biotechnology Corporation (NASDAQ:PDSB)


Share Price
$ 5.97
Change
-0.05 (-0.83 %)
Market Cap
$30.91 m
Proactive Investors - Run By Investors For Investors

PDS Biotechnology Corporation

PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers.

All of PDS’s products are based on the proprietary Versamune platform technology, which activates and...

EPIC: PDSB
Market: NASDAQ:PDSB
52-week High/Low: $23.60 / $5.04
Sector: Pharma & Biotech
Market Cap: $30.91 m
Website: www.pdsbiotech.com
col 3
col 4
col 5
col 6

Market Reports Including PDSB

VIEW ALL
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use